Sumatriptan Update information on pharmacology, mechanism of action and clinical use
Limmroth, V.; Waeber, C.; Diener, H.C.
Aktuelle Neurologie 22(1): 31-39
1995
ISSN/ISBN: 0302-4350 DOI: 10.1055/s-2007-1017885Document Number: 249153
Document emailed within 0-6 h
Related Documents
Guest, S. 2009: Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(3): 252-255Chauvin, M. 1991: Pharmacology and mechanism of action of opioids administered by the peridural route Cahiers d'Anesthesiologie 39(2): 87-90
Kress, H.G. 2009: Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine European Journal of Pain 13(3): 219-230
Pini, L.A.; Fabbri, L.; Cavazzuti, L. 1999: Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. the Sumatriptan 50 mg Italian Study Group International Journal of Clinical Pharmacology Research 19(2): 57-64
Kornel, L. 1973: On the effects and the mechanism of action of corticosteroids in normal and neoplastic target tissues: findings and hypotheses, with a review of information on intracellular steroid receptors in general Acta Endocrinologica. Supplementum 178: 1-45
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Oguchi, Y. 1998: Visual information processing and the mechanism of vision. Clinical application Nippon Ganka Gakkai Zasshi 102(12): 850-875
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
2006: Postmenopausal osteoporosis management--a Wegner Health Science Information Center information update. November 2006 South Dakota medicine: the journal of the South Dakota State Medical Association 59(11): 485
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Eridani, S. 1972: Cytarabine: mechanism of action and clinical application Haematologica 57(7): 341-358
Archakov, A.I.; Sel'tsovskiĭ, A.P.; Lisov, V.I.; Tsyganov, D.I.; Kniazhev, V.A.; Ipatova, O.M.; Torkhovskaia, T.I. 2002: Phosphogliv: mechanism of therapeutic action and clinical efficacy Voprosy Meditsinskoi Khimii 48(2): 139-153
Materia, E.; Bausano, G.; Corazziari, E. 1984: Laxatives: marketing, mechanism of action and clinical effects Recenti Progressi in Medicina 75(2): 202-208
Leshchinskiĭ, P.M.; Mareev, V.I. 1982: Sodium nitroprusside: mechanism of action and clinical application Terapevticheskii Arkhiv 54(5): 148-153
Suzuki, H. 1974: Mechanism of action of muscle relaxants and its clinical problems Masui. Japanese Journal of Anesthesiology 23(8): 679-692
Glants, R.M. 1980: Mechanism of action of transfused blood and its clinical importance Problemy Gematologii i Perelivaniia Krovi 25(10): 3-8
Köhnlein, W.; Jung, G. 1982: Neocarzinostatin: molecular mechanism of action and prospects for clinical use Arzneimittel-Forschung 32(11): 1474-1479
Paule, B.; Clerc, D.; Brion, N. 1998: Glucocorticoids and multiple myeloma. Mechanism of action, resistance and clinical use Annales de Medecine Interne 149(8): 502-507
Asakura, T. 1981: Update of pain pharmacology Masui. Japanese Journal of Anesthesiology 30(12): 1284-1291
Pirk, F.; Vosmík, J.; Skála, I. 1974: Lactulose--clinical experience, mechanism of action and its use in the x-ray diagnosis of the small intestine Vnitrni Lekarstvi 20(3): 251-256